Skip to main content

Blog

Strategic Country Grouping for UDI Submissions: reducing time/cost & compliance gaps

Category:

Regulatory authorities across countries are increasingly requiring medical device manufacturers to establish, maintain, and submit standardized device identification information to their respective UDI databases.

For global medical device organizations, managing UDI submissions across multiple countries can be a complex and resource-intensive exercise. Each market may have different regulatory requirements, data attributes, submission formats, terminology, validation rules, and timelines. Although the underlying device information is often similar across markets, differences in regulatory expectations can result in duplicated data preparation activities, multiple rounds of data cleansing, and increased operational effort.

One opportunity to improve efficiency is to adopt a strategic country grouping approach, particularly from a data preparation perspective.

Instead of treating every country as an independent UDI implementation, organizations can group countries based on similarities in regulatory requirements, data structures, mandatory attributes, terminology, and submission processes.

The objective is not necessarily to submit to multiple countries simultaneously, but to create a common data preparation strategy that supports multiple regulatory submissions efficiently.

Why Country Grouping is important for UDI Data Preparation

A significant portion of the effort involved in UDI submissions happens before the actual regulatory submission.

Typical data preparation activities include:
  • Extracting device master data from ERP, PLM, and/or multiple country specific Excels.
  • Identifying UDI-DI and associated device information.
  • Mapping source-system attributes to regulatory database requirements.
  • Standardizing terminology, classifications, and product descriptions.
  • Identifying country-specific mandatory and conditional fields.
  • Validating data completeness, consistency, and accuracy.
  • Preparing submission files in the required formats.
  • Managing data gaps, exceptions, and remediation activities.

When countries are handled independently, these activities are often repeated even when the underlying data requirements are substantially similar.

For example, a device’s manufacturer details, brand name, model number, packaging hierarchy, and basic product characteristics may be required across several regulatory markets.

By grouping countries with similar data requirements, organizations can create a common data preparation foundation and introduce country-specific variations only where necessary.

The guiding principle should be: Prepare common data once, enrich it where required, and generate country-specific submission outputs.

Recommended Country Grouping Strategy

Country grouping should be based on regulatory and data similarities rather than geographical proximity alone.

The following grouping model provides a practical starting point for global medical device manufacturers.

Proposed Country Grouping Matrix

The following matrix gives recommended approach.

Country ClusterMarketsData Preparation StrategyGrouping Recommendation
EuropeEU/EEA countriesCommon EU data templateHigh
North AmericaUSADedicated FDA mappingStandalone
OceaniaAustralia, New ZealandShared global data, separate regulatory mappingMedium
AsiaJapan, South KoreaCommon data foundation, separate country rulesMedium
Latin AmericaBrazil, Mexico, ArgentinaShared data foundation, localized outputsMedium

The grouping levels are strategic recommendations for data preparation, not an assertion that the countries share identical UDI obligations.

Move from Country-by-Country Preparation to a Global Data Strategy

The most effective way to manage global UDI submissions is to move away from a country-by-country data preparation mindset and adopt a reusable, globally standardized approach.

Grouping countries based on regulatory and data similarities can significantly improve operational efficiency. However, the objective should not be to force multiple countries into one submission model. Instead, organizations should establish a common global device data foundation with flexible country-specific regulatory mappings.

The recommended strategy is to:
  • Build one global UDI data preparation framework.
  • Group countries based on regulatory and data similarities.
  • Treat the EU as a common preparation cluster where applicable.
  • Maintain dedicated preparation streams for markets such as the US.
  • Reuse common device attributes across regional markets.
  • Introduce country-specific enrichment, validation, and submission outputs.
  • Continuously maintain data quality and regulatory change management.

Ultimately, the real opportunity is not simply to combine countries, but to combine data preparation activities wherever regulatory requirements allow.

This strategy can help medical device manufacturers reduce duplicate effort, improve data consistency, accelerate market readiness, and establish a scalable foundation for managing UDI requirements across global markets.

Looking to simplify global UDI data preparation and country-specific submissions? Explore how UDI Solutions by Visu UDI helps streamline UDI data management and support regulatory compliance across markets.

Share the Blog :

Previous Post

Next Post

Related Posts

Legacy Device UDI Submissions: Issues…

An important distinction is that legacy devices should not automat…

UDI Packaging Data Challenges: How to…

UDI is becoming an important part of medical device labeling, trac…

Master Data Management: Essential Str…

How may Products are in R&D and how many in commercial and in …

CONNECT WITH US

    Subscribe
    The First Step

    Let's talk about how DDi can help you